Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

48 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 56.7M shares of 92.2M outstanding shares and own 61.49% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (7.42M shares), Nextech Invest Ltd. (7.42M shares), Avidity Partners Management LP (7.42M shares), GREAT POINT PARTNERS LLC (6.93M shares), Blue Owl Capital Holdings LP (5.41M shares), VANGUARD GROUP INC (3.74M shares), Blackstone Inc. (2.44M shares), Nantahala Capital Management, LLC (1.94M shares), FRANKLIN RESOURCES INC (1.85M shares), and Ally Bridge Group (NY) LLC (1.76M shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.